Oncotarget: Predictors of immunotherapy benefit in Merkel cell carcinoma

(Impact Journals LLC) Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, " Merkel cell carcinoma (MCC) is a relatively rare cancer, with roughly 400 cases per 100,000 persons each year in the United States " .
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news